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This thesis begins with an overview of the state-of-the-art in tandem mass
spectrometry (MS/MS) analysis of glycopeptides. In this introduction, the primary focus
is on utilization of different ion dissociation techniques for MS/MS to obtain structural
information of N-glycopeptides. This includes a discussion of the importance of
complementary MS/MS methods to attain complete structural characterization of Nglycopeptides. Emerging methods involving the use of a single ion dissociation technique
for complete glycopeptide connectivity analysis were also presented. Next, the
application of collision-induced dissociation (CID) to provide both amino acid sequence
and monosaccharide connectivity for model N-glycopeptides was discussed in detail.
Implementation of varying collision energies to generate energy-resolved breakdown
curves suggested unique ranges of collision energies allowed glycan and peptide
fragments to be obtained. An online collision energy modulation was demonstrated to
allow both glycan and peptide fragments to be gathered in a single CID spectrum.
Finally, the role of proton mobility in dictating the energy-resolved CID behaviors of Nglycopeptides was examined. Energy-resolved CID studies in the context of different
precursor ion proton mobilities suggested the possibility that peptide and glycan cleavage
products could be deliberately accessed at predictable collision energies.
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Chapter 1
Tandem Mass Spectrometry of Glycopeptides: A Brief Overview
Portions of this chapter have appeared in:
V. Kolli, K. N. Schumacher, and E. D. Dodds, Bioanalysis 7: 113-131 (2015).
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Introduction
Unlike the other building blocks of a cell, oligosaccharides are able to form
branched structures of high complexity, and are thus considered among the most
analytically challenging for structural characterization.1 These challenges in structure
determination become compounded when these oligosaccharides (or, glycans) occur in
glycosylation, a post translational modification (PTM) of proteins.2 Glycosylation plays
significant roles in the functions of glycoproteins, and aberrant glycosylation can result
from or lead to various diseases including cancer, neurodegenerative disorders,
congenital disorders of glycosylation, and others.3-5 Understanding the compositional and
structural features of glycoproteins in their full molecular complexity is essential to
improving our understanding of their biological functions.
In general, glycosylation can be classified into the N- and O-linked types based on
the site of glycan attachment to the polypeptide chain. If glycans are attached to the side
chain of an asparagine residue in the context of an NXS or NXT sequon (with X being
any amino acid other than proline), this is termed as N-linked glycosylation. On the other
hand, if glycans are attached to the side chain of a serine or threonine residue, this is
termed O-linked glycosylation.6 Several analytical methods have been implemented to
characterize both N-linked and O-linked protein glycosylation. Among these methods,
mass spectrometry (MS) stands out as a promising approach, partly due to recent
advances in instrumentation to perform tandem mass spectrometry (MS/MS) analysis.7-10
These MS/MS methods can be implemented probe the structures of the glycoproteins by
bringing about informative fragmentation processes. Due to their large structures and
compositional heterogeneity, direct MS analysis of intact glycoproteins is seldom
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performed. Currently, most work to characterize glycoproteins is done on simplified or
isolated substructures of glycoproteins. Depending on the focus of interest, the MS based
approaches for glycoprotein characterization can be broadly classified into three
categories: glycomic approaches, proteomic approaches, or glycoproteomic approaches
(Figure 1.1).11 Among these three approaches, the work described in this thesis falls
within the scope of glycoproteomic approaches, which consider both the glycan and
peptide substructures, as well as their covalent connectivity. Such information is lost in
the glycan-centered and protein-centered approaches. To thoroughly analyze intact
glycopeptides, extensive research efforts have been directed towards development of
MS/MS strategies which provide information on both the peptide and the glycan.

Figure 1.1. Graphical summary of different approaches to glycoprotein analysis. Broadly categorized,
these include glycomics (characterization of glycans released from glycoproteins), proteomics
(identification of glycoproteins based on analysis of their non-glycosylated proteolysis products), and
glycoproteomics (characterization of site-specific connectivity between glycans and proteins through
analysis of glycosylated proteolysis products). The work presented in this thesis is focused on
glycoproteomics.
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Overview of Glycan and Peptide Fragmentation
The basic scheme for MS/MS analysis involves mass selection of the target of
interest. Subsequently, the precursor ions can be subjected to fragmentation using a
variety of methods. Based on the location and type of cleavage, the resulting fragments
can be labelled according to standard systems of nomenclature (Figure 1.2). In the case
of glycans, the Domon and Costello nomenclature is followed for labelling the
fragments.12 According to this nomenclature, B and Y fragments are obtained when the
glycosidic bond is cleaved, while C and Z fragments are obtained through cleavage of the
adjacent bond on the other side of the glycosidic oxygen. Lastly, A and X fragments can
be seen when cross-ring cleavages takes place. A, B, and C fragments retain the nonreducing end, while X, Y, and Z fragments retain the reducing end. Also, for A and X

Figure 1.2. Nomenclature for peptide (top) and glycan (bottom) fragments.
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fragments, the location of cross ring cleavages are shown as superscripts prior to the A or
X letter.12 Similarly for peptides, Roepstorff and Fohlman nomenclature is
implemented.13 Here, b and y fragments represents the cleavage of the peptide amide
bond, c and z fragments are from bond breakage between backbone N-Cα linkages, and
lastly a and x fragments arise from cleavage of the bond linking the Cα- carbonyl carbon.
Also, a, b, and c fragments will retain the N-terminus, while x, y, and z ions will contain
the C-terminus.13 A brief overview of the various MS/MS techniques that result in these
fragments follows.

Application of MS/MS Methods to Glycopeptides
Overview. The detection of putative glycopeptides by MS is usually followed by
MS/MS in order to confirm the monosaccharide and amino acid composition, and to
ascertain the monosaccharide connectivity and polypeptide sequence. While a
glycopeptide MS/MS experiment would ideally reveal all of these features, the structural
information actually obtained may or may not furnish this level of detail. Indeed, the
information obtained in MS/MS experiments depends greatly upon the nature of the
glycopeptide precursor ion (e.g., composition, charge carrier, charge state, etc.) and the
nature of the applied dissociation method (e.g., vibrational activation, electron capture /
electron transfer reactions, electronic excitation, etc.).11 These considerations have been
detailed in the context of glycopeptide analysis elsewhere.11 The following will provide a
brief discussion of recent developments and emerging strategies in the area of
glycopeptide MS/MS analysis.
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Use of complementary MS/MS methods. A variety of MS/MS methods are
commonly applied to biomolecule analysis.14 Most prevalent among currently available
techniques are those ion dissociation methods based upon either collisional vibrational
activation, or electron capture / electron transfer reactions.15-17 Since these methods lead
to structurally informative fragmentation processes through fundamentally different
mechanisms, the outcomes of these MS/MS methods often yield complementary
information. This complementarity has proven useful for proteomic analysis.18-19
Likewise, in the context of glycosylated peptide analysis, this orthogonality can be
exploited in order to gain highly informative MS/MS data. It is now well known that,
while vibrational activation / dissociation methods such as collision-induced dissociation
(CID) and infrared multiphoton dissociation (IRMPD) most readily lead to preferential
cleavage of glycosidic bonds, electron capture dissociation (ECD) and electron transfer
dissociation (ETD) lead to selective scission of N-C bonds along the polypeptide
backbone.20-23 As a result, a number of glycopeptide analysis workflows have been
devised in order to exploit multiple complementary MS/MS methods and thus gather
more detailed structural information on glycopeptide ions. For instance, Alley et al.
demonstrated a method based on LC-MS/MS with alternating CID and ETD events
which was shown to allow extensive characterization of model glycopeptides.24 In a
similar fashion, Perdivara et al. and Darula et al. combined CID and ETD in order to
characterize tryptic O-glycopeptides from biological mixtures.25-26 Analysis of Nglycopeptides was carried out by Cooper and coworkers using an LC-MS/MS method in
which the observation of carbohydrate oxonium ions following CID was used to trigger
ETD of the same precursor ion 27. In this way, CID and ETD were not simply alternated
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during the entire LC-MS/MS run; rather, ETD was only carried out if the CID spectrum
yielded evidence that a given precursor ion was a glycopeptide. CID neutral loss products
can also be used to trigger ETD for only those analytes likely to be glycosylated.28
Though not widely applied to glycopeptide analysis currently, we note that some
previously reported hybrid MS/MS approaches have significant potential to extend the
usefulness of MS/MS experiments that yield complementary structural information for
glycopeptides.29-34
Use of a single MS/MS method. While the combination of two MS/MS methods
can be highly informative regarding overall glycopeptide connectivity, significant effort
has also been aimed at gaining extensive glycopeptide connectivity data using a single
MS/MS technique. For example, photodissociation methods for MS/MS have achieved
some success in this regard.35-36 Irradiation of trapped ions with infrared photons to bring
about IRMPD is one such method 37. Studies by Adamson and Hakansson as well as
Bindila et al. demonstrated the ability of IRMPD to yield significant information on both
the glycan and peptide moieties of N-linked and O-linked glycopeptides, respectively.38-39
Lebrilla and coworkers also found IRMPD to effectively cleave both the carbohydrate
and peptide groups of N- and O-glycopeptides, with their studies focused on the
precursor ion characteristics (e.g., composition, charge carrier, charge polarity) which
tended to predispose a given precursor ion to one type of cleavage or the other.40-41
Irradiation of precursor ions with ultraviolet photons to result in ultraviolet
photodissociation (UVPD) has also found increased application to biomolecule MS/MS
analysis in recent years.42-43 The work of Zhang and Reilly as well as Madsen and
Brodbelt have established that UVPD yields concurrent fragmentation information on

8
both the glycan and the peptide for N-linked and O-linked glycopeptides, respectively.4445

In addition to photodissociation methods, certain CID-based strategies are being

developed with the goal of gathering both the monosaccharide connectivity and amino
acid sequence of glycopeptides. Such approaches are based on the observation that the
applied collision energy dictates the dominant fragment ion types appearing in a CID
spectrum. Thus, CID is capable of gaining broader use as a means of accessing peptide
sequence ions in addition to the more frequently noted glycan fragmentation products. In
the chapters that follow, work towards realizing these capabilities is presented.
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Abstract
Tandem mass spectrometry (MS/MS) of glycopeptides stands among the principal
analytical approaches for assessing protein glycosylation in a site-specific manner. The
aims of such experiments are often to determine the monosaccharide connectivity of the
glycan, the amino acid sequence of the peptide, and the site of glycan attachment. This
level of detail is often difficult to achieve using any single ion dissociation method;
however, precedent does exist for use of collision-induced dissociation (CID) to establish
either the connectivity of the oligosaccharide or the sequence of the polypeptide
depending upon the applied collision energy. Unfortunately, the relative energy
requirements for glycan and peptide cleavage have not been thoroughly characterized
with respect to specific physicochemical characteristics of the precursor ions. This report
describes case studies on the energy-resolved CID pathways of model tryptic
glycopeptides derived from Erythrina cristagalli lectin and bovine ribonuclease B. While
glycopeptide ions having disparate physical and chemical characteristics shared strikingly
similar qualitative responses to increasing vibrational energy deposition, the absolute
collision energies at which either glycan or peptide fragmentations were accessed varied
substantially among the precursor ions examined. Nevertheless, these data suggest that
the energy requirements for peptide and glycan cleavage may be somewhat predictable
based on characteristics of the precursor ion. The practical usefulness of these
observations was demonstrated through implementation of online collision energy
modulation such that both glycan and peptide fragmentation were captured in the same
spectrum, providing near-exhaustive glycopeptide characterization in a single
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experiment. Overall, these results highlight the potential to further extend the capabilities
of CID in the context of glycoproteomics.

Introduction
The site-specific analysis of protein glycosylation in complex biological samples
stands among the grand challenges facing modern post-genomic science.1-5 Accordingly,
there exists a strong demand for glycoproteomic capabilities to facilitate determination of
site-specific glycosylation in biological mixtures. This interest has been motivated in
large part by a continually expanding appreciation of protein-modifying oligosaccharides
as they pertain to numerous biological processes (e.g., fertilization; immune recognition;
host-pathogen interaction; etc.) and human disease states (e.g., cancer; congenital
disorders of glycosylation; neurodegenerative disorders, etc.).6-17 While protein
glycosylation analyses are often carried out with either a “glycocentric” (i.e.,
compositional and structural analysis of glycans released from glycoproteins) or a
“proteocentric” (i.e., identification of deglycosylated glycoproteins with indirect
glycosylation site localization) outlook, the loss of molecular detail imposed by glycan
release limits the specificity and potential for biological resolution that can be furnished
by such analyses.18 In order to map specific oligosaccharide structures to their
corresponding sites of protein attachment, the analytical scheme must preserve the
oligosaccharide-polypeptide connectivity until such a time that the chosen approach can
characterize the linkage.
One means of addressing this task entails the adaptation of bottom-up methods for
mass spectrometry (MS) based proteomics to characterize glycopeptides.19-21 While
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advantageous in terms of directness (glycan release is avoided, thus attachment sites need
not be merely inferred), this approach is subject to a number of analytical challenges.22, 23
The acquisition and subsequent interpretation of informative tandem mass spectrometry
(MS/MS) data for glycopeptide ions stand among the most pressing of these challenges.
Significant effort has been made to maximize the information content of glycopeptide ion
dissociation spectra, including those obtained through vibrational activation / dissociation
methods such as collision-induced dissociation (CID)24, 25 and infrared multiphoton
dissociation (IRMPD);26, 27 ion-electron and ion-ion reactions resulting in electron
capture dissociation (ECD)28, 29 or electron transfer dissociation (ETD);30, 31 and
irradiation with ultraviolet photons in order to achieve ultraviolet photodissociation
(UVPD).32, 33 One useful outcome of these investigations has been the observation of a
high degree of complementarity between the vibrational activation / dissociation spectra
and the electron capture / transfer dissociation spectra of glycopeptide ions. A number of
researchers have noted that while CID and IRMPD tend to preferentially cleave the
oligosaccharide moiety, ECD and ETD characteristically result in cleavage of only the
polypeptide backbone.34-38 This general behavior has proven very valuable, as application
of two complementary methods can enable thorough characterization of glycopeptide
composition and structure.39-43 Unsurprisingly, a number of other glycopeptide ion
dissociation pathways have been observed which do not fall within the domain of strictly
complementarity vibrational activation / dissociation and electron transfer / capture
dissociation.44-47 This includes numerous examples of vibrational activation / dissociation
methods providing information not limited to the carbohydrate group, but extending to
the amino acid sequence of the peptide group as well. For example, fragmentation of
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glycopeptide amino acid chains has been noted in IRMPD,26, 27, 48, 49 low-energy beamtype CID,50-54 and high-energy beam-type CID.55-57 As noted in these studies, the energy
required to achieve scission of the peptide backbone is generally much greater than that
necessary for cleavage of the glycan group. These energy-resolved fragmentation
channels are of significant analytical utility; however, the various dissociation pathways
have not been thoroughly studied with respect to specific physical and chemical
characteristics of glycopeptide precursor ions. In particular, the present understanding of
factors which dictate the energetic requirements for peptide backbone fragmentation is
not well developed, despite even relatively recent energy-resolved CID studies of
glycopeptides (which did not investigate the fragmentation of the peptide group).25, 58
This type of understanding would be of great practical use, as it could conceivably allow
precursor ion characteristics to inform the setting of CID collision energies such that
glycan or peptide cleavages are more deliberately accessed. If well characterized, the
diverse fragmentation pathways of glycosylated peptide ions can be highly advantageous
in increasing the density of structural information yielded by MS/MS. Moreover, as
essentially all MS/MS instruments are capable of CID, the ability to extract maximum
structural information regarding both the oligosaccharide and the polypeptide using lowenergy vibrational activation / dissociation alone is particularly appealing.
The research reported here is focused upon a detailed study of the energy-resolved
CID characteristics of tryptic glycopeptides chosen as models for this study due to their
disparate characteristics. The first of these was a 17 amino acid glycopeptide carrying a
seven monosaccharide paucimannosidic glycan (i.e., containing the trimannosyl core with
added fucose and xylose residues). The second was a six amino acid glycopeptide
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carrying a seven monosaccharide high mannose glycan (i.e., containing the trimannosyl
core with added mannose residues). These model glycopeptides, each harboring two
basic amino acid side chains, were studied as their doubly protonated and triply
protonated precursor ions. This allowed the energy requirements of the various
fragmentation pathways to be evaluated both in the presence and absence of readily
mobile protons. Although there were considerable quantitative differences in the absolute
collision energies at which different dissociation channels were accessed, these
experiments revealed a striking concordance with respect to qualitative trends in the
energy-resolved CID behaviors of these analytes. In all cases, Y-type fragmentations of
the oligosaccharide group comprised the lowest-energy dissociation pathways; however,
with increasing vibrational energy deposition these primary fragment ions gave rise to
secondary product ions dominated by the Y1 fragment (peptide plus reducing terminal
monosaccharide) and ultimately a collection of tertiary fragments including the Y0
fragment (complete glycan loss) and an abundance of peptide b and y fragments. Despite
the quantitative differences in energy-resolved CID of the precursor ions examined, these
data suggest that key dissociation characteristics may be somewhat predictable based on
characteristics of the precursor ion. Finally, these observations enabled the design and
implementation of a multi-energy CID experiment which permitted different energyresolved dissociation channels to be captured in a single information-rich CID spectrum
which yielded both the glycan connectivity and the amino acid sequence. In summary,
the present results suggest means of taking more complete advantage of CID capabilities
for glycopeptide structure characterization.
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Materials and Methods
Chemicals. Bovine ribonuclease B (BRB), ammonium bicarbonate, urea,
dithiothreitol, iodoacetamide, proteomics grade trypsin, imidazole, and formic acid were
purchased from Sigma-Aldrich (St. Louis, MO, USA). Erythrina cristagalli lectin (ECL)
was obtained from Vector Labs (Burlingame, CA, USA). HPLC grade acetonitrile was
acquired from Fisher Scientific (Fair Lawn, NJ, USA). HPLC grade water was purchased
from Burdick & Jackson (Muskegon, MI, USA).
Sample preparation. For each glycoprotein of interest, a 50 µL aliquot of 2 µg/µL
glycoprotein solution in 8 M urea and 50 mM NH4HCO3 (pH 7.5) was treated with 10 µL
of 450 mM dithiothreitol in 50 mM NH4HCO3 (pH 7.5). This mixture was incubated for
1 h at 55°C for disulfide bond reduction. A 10 µL portion of 500 mM iodoacetamide in
50 mM NH4HCO3 (pH 7.5) was then added. This was followed by incubation for 1 h in
the dark at ambient temperature for thiol acetamidation. The urea content of the sample
was then diluted to < 2 M by addition of 175 µL 50 mM NH4HCO3 (pH 7.5). A 5 µL
aliquot of 0.5 µg/µL of trypsin was next added, and this solution was allowed to incubate
for 18 hours at 37°C. The digest was subsequently vacuum centrifuged using a Speed
Vac SC110 (Thermo Savant, Holbrook, NY, USA) to reduce the volume of the solution
to approximately 10 µL. The digest was reconstituted to a total volume of 100 µL by
addition of 0.1% formic acid. To enrich the glycosylated fraction of tryptic peptides, solid
phase extraction was performed using zwitterionic hydrophilic interaction liquid
chromatography (ZIC-HILIC) in a pipette tip format (Protea Biosciences, Somerset, NJ,
USA). Each ZIC-HILIC tip was wetted with water, equilibrated with 80% acetonitrile /
0.1% formic acid, then loaded with a portion of the reconstituted digest in 80%
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acetonitrile (i.e., 4 µL of reconstituted digest plus 16 µL acetonitrile). Each tip was then
washed with 80% acetonitrile / 0.1% formic acid. Finally, elution was performed using
0.1% formic acid.
Mass spectrometry. All analyses were conducted using a Synapt G2 HDMS
quadrupole time of flight (Q-TOF) hybrid mass spectrometer (Waters, Manchester, UK).
The instrument was fitted with a home-built static nanoflow electrospray ionization
(nESI) stage which delivered the capillary potential by means of a platinum wire placed
in contact with a small portion of analyte solution contained in a borosilicate emitter.
Samples of approximately 10 µL purified digest or purified digest spiked to include 10
mM in imidazole (to enhance the abundance of lower charge states produced by nESI)
were placed into nESI emitters using a 10 µL syringe (Hamilton, Reno, NV, USA). The
emitters were fashioned in-house from 1.5 - 1.8 x 100 mm Corning Pyrex melting point
capillaries (Corning, NY, USA) using a vertical micropipette pipette puller (David Kopf
Instruments, Tujunga, CA, USA). Ionization by nESI was conducted using a capillary
potential of 1.0 - 1.4 kV, a sampling cone voltage of 15 - 35 V, and an extraction cone
voltage of 2 - 4 V. Source temperature was maintained at 80°C. Precursor ions of interest
were quadrupole selected and subjected to CID such that the trap region stacked ring ion
guide of the instrument served as the collision cell. Argon was used as the collision gas at
a pressure of approximately 5.0 x 10-3 mbar within the collision cell. Collision energy
was modulated by adjusting the static DC offset (U) between the collision cell and the
stacked ring ion guide of the ion source region. Direct infusion spectra were acquired for
approximately one minute.
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Data handling. Spectrum acquisition and analysis was performed in MassLynx
4.1 (Waters), and further data processing and visualization were carried out using
SigmaPlot 10.1 (Systat, Chicago, IL, USA) and using custom routines written and
implemented in IGOR Pro 6.3 (WaveMetrics, Lake Oswego, OR, USA). Where practical,
product ions resulting from cleavage of the carbohydrate group were assigned according
to the nomenclature of Domon and Costello.59 Occasionally, glycan fragmentations or
combinations thereof could not be unambiguously or conveniently assigned using these
formalisms. In such instances, the fragments were assigned by indicating monosaccharide
losses from the precursor. Product ions involving scission of the peptide were assigned in
accord with the nomenclature of Roepstorff and Fohlman.60 When naming and referring
to product ions, lower case letters were used to specify peptide fragmentation, while
upper case letters were used to indicate oligosaccharide cleavage. For the sake of clarity,
product ions resulting from small neutral losses (e.g., H2O, NH3) from the precursor or
other fragments were assigned but not labelled in the spectra presented below. Glycan
structures were diagrammed using the monosaccharide symbology of Varki et al.61
Peptide sequences were presented using standard one-letter amino acid notation, while
monosaccharide names were abbreviated as follows: GlcNAc, N-acetylglucosamine;
Man, mannose; Fuc, fucose; Xyl, xylose.

Results and Discussion
CID of ECL glycopeptide ions. Upon nESI-MS analysis, the ZIC-HILIC purified
tryptic digests of ECL yielded a major peak corresponding to the glycopeptide ion
[SKPAQGYGYLGVFNNSK + GlcNAc2 Man3 Fuc1 Xyl1 + 3H]3+ (monoisotopic m/z =

22
1000.8). This glycopeptide was an attractive model analyte for our initial studies because,
as discussed below, the MS/MS behavior of this analyte has been well-studied by others
in the past (particularly, with respect to the complementarity of vibrational activation
methods and electron capture / transfer methods for glycopeptide analysis). The ion was
quadrupole selected and subjected to CID at a variety of collision energies. As shown in
Figure 2.1a-b, at a collision energy of U = 17.5 V the CID spectrum is dominated by Ytype glycosidic cleavages of the carbohydrate moiety. Sequential loss of individual
monosaccharides occurred in various orders, ultimately resulting in a major fragment ion
which corresponded to the Y1α+Y1β double cleavage product (i.e., the peptide group plus a
single remaining GlcNAc residue linked to the asparagine side chain). Not unexpectedly,
the CID spectrum of this glycopeptide ion closely resembled the vibrational activation /
dissociation spectra obtained by other researchers using IRMPD,35 ion trap CID,37 and
beam-type CID in a Q-TOF.38 It should be pointed out that the studies cited above were
conducted on two variants of the target glycopeptide: one in which the residue two
positions N-terminal of the glycosylation site was isoleucine, and another in which the
isoleucine residue was replaced by a valine residue. Although this substitution of one
aliphatic residue for another is unlikely to significantly affect the overall dissociation
behavior of these glycopeptide variants, we note here that the present studies have been
carried out using the valine-containing variant. In line with expectations, some very
dissimilar CID results were obtained at somewhat higher collision energies. As depicted
in Figure 2.1c-d, at a collision energy of U = 37.5 V the spectrum changed dramatically
in both overall appearance and in information content. Under these conditions, the base
peak of the CID spectrum remained the Y1 α +Y1β fragment, although a number of major
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ions in the spectrum were assigned as b- and y-type peptide sequence fragments. The
observed product ions resulted in 56.3% sequence coverage for the peptide backbone,
owing to six b ions and eight y ions representing cleavage of nine of the 16 peptide amide

Figure 2.1. CID of the triply protonated ECL glycopeptide. The CID spectrum acquired at U = 17.5 V
(a) exhibited only glycan cleavage, as shown in the accompanying diagram (b). The CID spectrum
acquired at U = 37.5 V (c) exhibited mainly peptide fragments following glycan loss, as shown in the
accompanying diagram (d).
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bonds. Notably, the CID sequence coverage reported here is quite reasonable when
compared to those previously reported for this glycopeptide ion by ECD or ETD.
Hakansson et al. obtained 68.8% sequence coverage by ECD (nine c ions and two z ions
representing cleavage of 11 out of 16 N-C α bonds),35 while McLuckey and coworkers
achieved 75.0% sequence coverage by ETD (11 c ions and 12 z ions representing
cleavage of 12 out of 16 N-Cα bonds).38
To more completely delineate the energy-resolved CID behavior of this model
glycopeptide, the peak areas of the [M+3H]3+ precursor ion and the corresponding
product ions (or classes of product ions) were plotted as a function of U (Figure 2.2).
As the collision energy was increased, the precursor ion was depleted and first yielded an
assortment of Yn glycan fragments, where n > 1. The relative proportion of these primary
product ions crested at approximately U = 17.5 V, corresponding to the spectrum
presented in Figure 2.1a. Further increasing the collision energy resulted in diminished

Figure 2.2. Energy-resolved CID plot for the triply protonated ECL glycopeptide. The normalized peak
area of each ion or group of ions is plotted as a function of the collision energy, expressed as the applied
DC offset. Each data point represents the mean of four replicate measurements; error bars, where
visible, represent the standard deviation.
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relative abundance of the Yn>1 ions, with concomitant increase in proportion of Y1
fragments, including Y1α, Y1β, and the Y1α +Y1β double cleavage product. As the collision
energy was elevated to U > 32.5 V, the continued diminution of Yn>1 fragments was
accompanied by declining abundance of Y1 fragments. These reductions coincided with
the production of a modest fraction of the Y0 fragment (i.e., loss of the entire
oligosaccharide) and a substantial abundance of b- and y-type peptide fragments. This
region of the energy-resolved CID plot corresponds to the spectrum given in Figure 2.1c.
At U = 40.0 V, peptide b and y ions accounted for approximately 50% of the integrated
peak area of the CID spectrum. Further increasing the collision energy led to loss of ion
signal. Overall, these energy-resolved CID results confirm that, while only glycan
fragments are yielded via the lowest energy dissociation pathways, significant
information regarding the peptide sequence can be obtained as later generations of
fragment ions evolve at higher collision energies.
Because the glycopeptide under investigation included two particularly basic sites
(the ε amino groups of the two lysine residues), the triply protonated ion discussed above
contains one readily mobile proton.62, 63 In order to evaluate how the absence of mobile
protons would influence the dissociation channels of this model glycopeptide, the doubly
protonated ion [SKPAQGYGYLGVFNNSK + GlcNAc2 Man3 Fuc1 Xyl1 + 2H]2+
(monoisotopic m/z = 1500.7) was generated by adding imidazole to the ZIC-HILIC
enriched glycopeptide preparation. As illustrated in Figure 2.3, the [M+2H]2+ precursor
ion also yielded CID spectra containing predominantly carbohydrate Y fragments (Figure
2.3a-b) at lower collision energies (in this example, U = 47.5 V), while relatively high
collision energies (in this example, U = 65.0 V) brought about glycan loss with
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subsequent fragmentation of the polypeptide chain (Figure 2.3c-d). In comparing the
product ion spectra of the [M+2H]2+ ion (i.e., with only partially mobile protons) to those
of the [M+3H]3+ ion (i.e., with one readily mobile proton), it was found that, at

Figure 2.3. CID of the doubly protonated ECL glycopeptide. The CID spectrum acquired at U = 47.5
V (a) exhibited only glycan cleavage, as shown in the accompanying diagram (b). The CID spectrum
acquired at U = 65.0 V (c) exhibited mainly peptide fragments following glycan loss, as shown in the
accompanying diagram (d).

27
appropriately chosen collision energies, the two precursors were able to yield much the
same sequence information. The fragments providing the glycan connectivity were
equivalently informative for both precursor ion charge states at the relatively low values
of U, and the same peptide sequence coverage was obtained at the relatively high values
of U. For the doubly charged precursor, the sequence coverage of 56.3% was obtained
on the basis of six b ions and nine y ions. Although the two charge states of this
glycopeptide were able to supply similarly revealing CID spectra, not unexpectedly they
did so at quite different settings of U. The energy-resolved CID plot for the doubly
charged precursor ion (Figure 2.4) was generated in the same manner as for the triply
charged precursor ion. Although shifted to higher energies, the same general behavior
was observed wherein Yn>1 fragments of the oligosaccharide were the first fragments to
appear, and as the collision energy was increased these fragments gave way to the Y1
carbohydrate fragments followed by Y0 glycan loss and finally b and y fragmentation of

Figure 2.4. Energy-resolved CID plot for the doubly protonated ECL glycopeptide. The normalized
peak area of each ion or group of ions is plotted as a function of the collision energy, expressed as the
applied DC offset. Each data point represents the mean of three replicate measurements; error bars,
where visible, represent the standard deviation.
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the peptide chain. It is important to note that the increases in U values necessary to
access the various fragmentation pathways was not solely due to differences in ion
kinetic energy prior to collision. Applying a linear fit to the inflection point regions of the
precursor ion survival curves allowed calculation of the U values which corresponded to
depletion of half the precursor ion signal. These 50% precursor ion survivals occurred at
U = 14.9 V for the [M+3H]3+ glycopeptide ion and U = 38.8 V for the [M+2H]2+
precursor. The precursor ion kinetic energy (Ek) relates to the accelerating potential U
according to:
Ek = zeU

Equation 2.1

where z is the number of charges and e is the fundamental charge. The initial kinetic
energies resulting in 50% precursor ion survival were therefore 44.7 eV for the [M+3H]3+
and 77.6 eV for the [M+2H]2+ ion. These observations are consistent with the mobile
proton model, and serve to reiterate the critical importance of collision energy setting
upon the information content of glycopeptide CID spectra, and how dramatically this
dependence can vary depending on the charge state.
CID of BRB glycopeptide ions. In order to address whether the dissociation
behaviors observed for the ECL glycopeptide might be generally true of other
glycopeptides, another model analyte was selected for study. The ZIC-HILIC enriched
BRB digest exhibited a number of glycopeptide ion signals on nESI-MS analysis. The
various peaks represented the microheterogeneity of the BRB glycosylation site, as well
as an assortment of fully and partially tryptic digestion products. Among the most
abundant signals was the glycopeptide ion [SRNLTK + GlcNAc2 Man5 + 2H]2+
(monoisotopic m/z = 968.6). This model glycopeptide serves as an interesting contrast to
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the ECL glycopeptide, in that they harbor different classes of N-glycans
(paucimannosidic in the case of the ECL glycopeptide; high mannose in the case of BRB)
and have polypeptide groups of quite different lengths (17 amino acid residues in the case
of the ECL glycopeptide; six in the case of the BRB glycopeptide). CID spectra of the
[M+2H]2+ BRB glycopeptide ion are provided in Figure 2.5. Much as was noted for the
ECL glycopeptide, at relatively low collision energy only the glycan was cleaved (Figure
2.5a-b).Conducting CID at U = 30.0 V generated a complete series of Y-type
oligosaccharide fragmentation products, which provided the complete glycan
composition for this glycopeptide. This spectrum presented in Figure 2.5a was found to
be less complex than the analogous spectrum of the ECL glycopeptide (Figure 2.1a)
owing to the lesser number of monosaccharide masses involved, and the correspondingly
fewer possible product ion masses arising from oligosaccharide fragmentation. When
CID was performed at U = 55.0 V, the dissociation spectrum became dominated by
peptide fragments (Figure 2.5c-d). These higher energy dissociation pathways yielded
product ions covering 80% of the peptide sequence (three b ions and two y ion
representing cleavage of four out of five peptide amide bonds). These observations
reinforce the findings for the ECL glycopeptide, where CID spectra alternately produced
glycan fragmentation or peptide fragmentation at depending on the applied collision
energies. In one contrast to the ECL glycopeptide, at elevated collision energies the BRB
glycopeptide was found to yield cross-ring cleavage of the terminal GlcNAc residue
(0,2X1). Furthermore, the BRB glycopeptide exhibited some examples of peptide
fragmentation without complete loss of the glycan. For instance, the 0,2X1+b5 and Y1+b5
internal fragments were among the most abundant signals in the U = 55.0 V CID
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spectrum (Figure 2.5c). This highlights the possibility that glycan and peptide
dissociation channels may take place concurrently under certain circumstances (e.g.,
when a particularly favored peptide backbone cleavage is available). Similar findings

Figure 2.5. CID of the doubly protonated BRB glycopeptide. The CID spectrum acquired at U = 30.0
V (a) exhibited only glycan cleavage, as shown in the accompanying diagram (b). The CID spectrum
acquired at U = 55.0 V (c) exhibited mainly peptide fragments following glycan loss, as shown in the
accompanying diagram (d).
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have previously been noted in vibrational activation / dissociation of O-glycopeptides
containing proline residues.27, 64 In those instances, the proline effect65-67 rendered peptide
fragmentation competitive with glycan loss.
The energy-resolved CID behavior of the doubly protonated BRB glycopeptide is
presented in Figure 2.6. On comparison to the triply protonated ECL glycopeptide ion
(Figure 2.2), the onset of dissociation for the triply protonated BRB glycopeptide is
occurred at somewhat higher collision energies, with the 50% precursor ion survival
being reached at U = 26.2 V (corresponding to Ek = 52.4 eV) for the [M+2H]2+ BRB
glycopeptide, as compared to U = 14.9 V (corresponding to Ek = 44.7 eV) for the
[M+3H]3+ ECL glycopeptide. Such differences were not unexpected, given the presence
of a readily mobile proton in the case of the triply protonated ECL glycopeptide ion, and
the availability of only partially mobile protons in the case of the doubly protonated BRB
glycopeptide ion.

Figure 2.6. Energy-resolved CID plot for the doubly protonated BRB glycopeptide. The normalized
peak area of each ion or group of ions is plotted as a function of the collision energy, expressed as the
applied DC offset. Each data point represents the mean of three replicate measurements; error bars,
where visible, represent the standard deviation.
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It should be noted that the substantially different molecular weights of the two
glycopeptides (monoisotopic mass of 2999.3 u for the ECL glycopeptide; 1936.2 u for
the BRB glycopeptide) and the commensurate disparity in their vibrational degrees of
freedom also contributes to quantitative differences in the energy-resolved CID behavior.
Aside from the absolute collision energies at which different kinds of dissociation
pathways were accessed, the two sets of energy-resolved CID data were in strong
agreement regarding the initial appearance of Yn>1 glycan fragments followed by Y1
glycan fragments, which in turn ultimately yielded Y0 fragment ions (complete glycan
loss) and peptide b and y fragment ions. Interestingly, the energy dependences of various
dissociation pathways qualitatively mirrored those of the ECL glycopeptide ions. Indeed,
these energy-resolved CID data were in strong concordance regarding the initial
appearance of Yn>1 glycan fragments followed by Y1 glycan fragments, which in turn
ultimately yielded Y0 fragment ions (complete glycan loss) and peptide b and y fragment
ions. These qualitative similarities in the energy-dependent dissociation behavior is rather
remarkable, given the significant differences between the glycopeptides in terms of
structure and composition.
To again probe the influence of proton mobility on the information content of the
CID spectra, the [SRNLTK + GlcNAc2 Man5 + 3H]3+ (monoisotopic m/z = 645.7) ion
was next studied. This ion was observed along with the corresponding doubly charged
ion upon nESI-MS analysis of the purified BRB digest, although in less abundance. In
contrast to the BRB [M+2H]2+ ion, this BRB [M+3H]3+ ion has a number of ionizing
protons which exceeds the number of basic amino acid side chains, and thus has a readily
mobile proton. As illustrated in Figure 2.7, CID at U = 10.0 V produced only Y-type
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glycan fragments (Figure 2.7a-b), while at U = 40.0 V peptide b and y ions were
observed (Figure 2.7c-d). The product ions arising from polypeptide cleavage provided
60% sequence coverage (three b ions and one y ion representing cleavage of three out of

Figure 2.7. CID of the triply protonated BRB glycopeptide. The CID spectrum acquired at U = 10.0 V
(a) exhibited only glycan cleavage, as shown in the accompanying diagram (b). The CID spectrum
acquired at U = 40.0 V (c) exhibited mainly peptide fragments following glycan loss, as shown in the
accompanying diagram (d).
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five peptide bonds). Predictably, the energy-resolved CID plot for the triply protonated
BRB precursor ion exhibited lower dissociation onset energies as compared to the doubly
protonated precursor, owing to both the differing charge states (and thus different
dependence of Ek upon U) as well as the differences in proton mobility (Figure 2.8).
These considerations notwithstanding, the general observation that glycan connectivity
and peptide sequence can be differentially accessed at different collision energies again
held true for this precursor ion.
Multi-energy CID of the ECL and BRB glycopeptides. The energy-resolved CID
data discussed above served to suggest the intriguing possibility of capturing
oligosaccharide and polypeptide sequence information in a single mass spectrum. In
order to achieve this, online collision energy modulation was applied during direct
infusion acquisition of CID spectra in order to sample informative dissociation channels

Figure 2.8. Energy-resolved CID plot for the triply protonated BRB glycopeptide. The normalized peak
area of each ion or group of ions is plotted as a function of the collision energy, expressed as the applied
DC offset. Each data point represents the mean of three replicate measurements; error bars, where
visible, represent the standard deviation.
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of different energetic requirements. The multi-energy CID spectrum of the [M+3H]3+
ECL glycopeptide ion is presented in Figure 2.9. The spectrum exhibited a wealth of
product ions which collectively resulted in complete coverage of the glycan Y-type ions
and 56% peptide sequence coverage (six b ions and nine y ions accounting for scission of
nine of the 16 peptide amide bonds). The multi-energy CID spectrum for the [M+2H]2+
ECL glycopeptide ion (Figure 2.10) provided essentially the same information content.
Also noteworthy is that the multi-energy CID spectra obtained through online collision
energy modulation compare favorably to the dissociation spectra obtained at a single
collision energy (cf. Figure 2.1b, Figure 2.1d, and Figure 2.9b). Similarly, multi-energy
CID of the [M+2H]2+ BRB glycopeptide (Figure 2.11) was revealing of a complete series
of Y-type glycosidic cleavages as well as 80% peptide sequence coverage. Again,

Figure 2.9. Multi-energy CID of the triply protonated ECL glycopeptide. The CID spectrum (a) was
acquired via online switching between two collision energies: U = 17.5 V and U = 37.5 V. These
correspond to the collision energies applied in Figure 2.1a and Figure 2.1c, respectively. Peak
assignments are the same as those shown in Figure 2.1a (labeled here with blue circles) and Figure
2.1c (labeled here with red squares). An abundance of both glycan and peptide fragments were
observed, as shown in the accompanying diagram (b).
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Figure 2.10. Multi-energy CID of the doubly protonated ECL glycopeptide. The CID spectrum (a) was
acquired via online switching between two collision energies: U = 47.5 V and U = 65.0 V. These
correspond to the collision energies applied in Figure 2.3a and Figure 2.3c, respectively. Peak
assignments are the same as those shown in Figure 2.3a (labeled here with blue circles) and Figure
2.3c (labeled here with red squares). An abundance of both glycan and peptide fragments were
observed, as shown in the accompanying diagram (b).

comparable connectivity information was obtained upon multi-energy CID analysis of an
alternative charge state of the analyte (in this case, the [M+3H]3+ BRB glycopeptide ion;
Figure 2.12). Furthermore, the multi-energy CID results for the BRB glycopeptide were
found to be of approximately equivalent information content as was achieved in the
individual, static collision energy spectra (cf., Figure 2.5b, Figure 2.5d, and Figure
2.11b). Overall, the modulation of collision energy without interrupting spectrum
acquisition was found to be a viable approach to obtaining highly informative CID
spectra which address the structures of both the glycan and peptide moieties.
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Figure 2.11. Multi-energy CID of the doubly protonated BRB glycopeptide. The CID spectrum (a) was
acquired via online switching between two collision energies: U = 30.0 V and U = 55.0 V. These
correspond to the collision energies applied in Figure 2.5a and Figure 2.5c, respectively. Peak
assignments are the same as those shown in Figure 2.5a (labeled here with blue circles) and Figure
2.5c (labeled here with red squares). An abundance of both glycan and peptide fragments were
observed, as shown in the accompanying diagram (b).

Conclusions
Although vibrational activation / dissociation MS/MS methods are perhaps best
known for the ability to provide information on the carbohydrate moiety of
glycopeptides, these data underscore and extend previous observations that, at
appropriately chosen collision energies, substantial peptide sequence information can be
obtained via low-energy beam-type CID. This was found to be true of four model
glycopeptide ions which were quite dissimilar in a number of other respects (glycan type
and composition; peptide size and composition), and were each investigated as
protonated ions having charge states that provided differing proton mobilities. Despite
these variables, the analyte ions studied herein adhered to strikingly similar energy-
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Figure 2.12. Multi-energy CID of the triply protonated BRB glycopeptide. The CID spectrum (a) was
acquired via online switching between two collision energies: U = 10.0 V and U = 40.0 V. These
correspond to the collision energies applied in Figure 2.7a and Figure 2.7c, respectively. Peak
assignments are the same as those shown in Figure 2.7a (labeled here with blue circles) and Figure
2.7c (labeled here with red squares). An abundance of both glycan and peptide fragments were
observed, as shown in the accompanying diagram (b).

resolved CID behaviors from a qualitative standpoint. In each case, Yn>1 carbohydrate
cleavage was observed as the lowest-energy, first generation dissociation pathway. With
increasing collision energy, production of the Y1 glycan fragment was observed, which in
turn gave rise to the Y0 product along with b and y ions. Based on the energy-resolved
CID precursor and product ion abundance curves, the peptide b and y ions appear to be
tertiary fragments which, accordingly, have much higher appearance energy thresholds as
compared to the glycan-related scissions. Our findings in aggregate serve to suggest that
these dissociation behaviors may be quite general among a diverse range of glycosylated
peptides bearing different glycan classes and various peptide characteristics.
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The higher energy required to access peptide-informative dissociation channels
may in part explain why such ions are sometimes not observed. For example, low-energy
CID in an ion trap would not be expected to yield consecutive fragmentation in single
MS/MS experiment, since this method only imparts translational energy to the precursor
ion. Likewise, IRMPD may in some cases be too slow an activation process to provide
extensive peptide sequence information, even though IRMPD is in principle capable of
accessing consecutive dissociation products. Although the present findings may be of less
usefulness in conjunction with these “slow heating”68 vibrational activation methods,
they can be of immediate analytical utility when analysis is carried out using any lowenergy, beam-type CID instrument, such as tandem quadrupoles, quadrupole time-offlight hybrids, and various other hybrid mass spectrometers which enable beam-type
collisional activation. This includes “higher-energy collisional dissociation” (HCD),
which is merely a vendor-specific implementation and terminology for low-energy beamtype CID.
While qualitatively quite similar, there were some important quantitative
differences in the energy-resolved CID data among the model glycopeptide ions
investigated here. Clearly, the composition, charge state, and proton mobility of the
precursor ion exert great influence on the absolute collision energies at which various
classes of dissociation products are observed. Accordingly, the ability to collect both
glycan and peptide information in a multi-energy CID spectrum hinges upon appropriate
selection of the applied U values. Thus, further study of the energy dependence of
glycopeptide fragmentation pathways seems warranted. In this respect, some theoretical
progress has been made towards predicting glycopeptide tandem mass spectra on the
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basis of a kinetic model; however, thus far this has only been performed from the
standpoint of ion trap CID under conditions which would not be expected to lead to
peptide sequence information.69 We are currently pursuing this line of inquiry from an
experimental standpoint. Based on energy-resolved CID studies of families of
glycopeptides with key differences in composition and charge state, we find that the
general conclusions of the present study extend to numerous other glycopeptide analytes,
and further that it may be possible to predict collision energies that result in specific
fragment types (indeed, the charge state and degrees of freedom corrected 50% precursor
ion survival energies seem to correlate well with proton mobility (Table 2.1).

Table 2.1. CID collision energies (U) corresponding to 50% precursor ion survival, and the corresponding
precursor ion charge states (z) and vibrational degrees of freedom (f). The charge state and degrees of
freedom corrected 50% precursor ion survival energies are given in the rightmost column, and have each
been multiplied by a factor of 100 to yield more convenient figures. Within the glycopeptide compositions,
amino acid residues with basic side chains are shown in bold, while the glycosylated asparagine residue is
underlined. The number of charge-carrying protons (nH+) are also indicated relative to the number of basic
amino acid side chains (nB).

Glycopeptide Composition

z

f

ΔU
(V)

(zΔU/f)
*100

[SKPAQGYGYLGVFNNSK+GlcNAc2Man3Xyl1Fuc1+3H]3+

3

1230

14.9

3.63

[SRNLTK+GlcNAc2Man5+3H]3+

3

804

5.5

2.05

[SKPAQGYGYLGVFNNSK+GlcNAc2Man3Xyl1Fuc1+2H]2+

2

1227

38.8

6.32

[SRNLTK+GlcNAc2Man5+2H]2+

2

801

26.2

6.54

nH+>nB

nH+=nB

Finally, we note that the development of an enhanced understanding of how CID
yields peptide information is quite significant given that the alternatives for this task ECD and ETD - are not as widely available on as eclectic an array of MS instruments as

41
compared to CID. Thus, there is potential for substantial impact of these findings in the
context of glycoproteomics. The major advantage of ETD is that the peptide backbone
can be fragmented without elimination of the glycan, thus allowing unambiguous and
direct assignment of the site of modification. However, in many cases involving Nglycosylation, loss of the glycan does not preclude site localization owing to the
specificity of N-glycan attachment to only asparagine residues within the context of NXT
or NXT consensus sequon (where X is any amino acid residue except proline). For tryptic
N-glycopeptides which contain only one potential N-glycosylation site, glycan loss at the
stage of MS/MS does not pose a significant limitation for site localization. Moreover, we
note that modulating U values to capture spectra at different collision energies can be
done in a matter of a few milliseconds, making this approach at least as fast (and
potentially faster) than online switching to ETD. This presents an advantage from the
standpoint of sampling LC-MS peaks. Overall, these results indicate the possibility of
some generally applicable principles of energy-resolved glycopeptide ion CID behaviors
of glycosylated peptide ions, while concomitantly underscoring the need for further study
of the absolute collision energies necessary to access desired types of fragmentation
information. The accomplishment of these goals would undoubtedly bring considerable
analytical benefits to the field of glycoproteomics with regards to maximizing the
structural information content of glycopeptide CID spectra.
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Chapter 3
The Role of Proton Mobility in Determining the Energy-Resolved
Vibrational Activation / Dissociation Channels of N-Glycopeptide Ions
Portions of this chapter will appear in:
V. Kolli, H. A. Roth, G. De La Cruz, G. S. Fernando, and E. D. Dodds (submitted).
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Abstract
Site-specific glycoproteomic analysis largely hinges on the use of tandem mass
spectrometry (MS/MS) to identify glycopeptides. Experiments of this type are usually
aimed at drawing connections between specific oligosaccharide structures and their
specific sites of attachment to the polypeptide chain. These determinations inherently
require ion dissociation methods capable of interrogating both the monosaccharide and
amino acid connectivity of the glycopeptide. Collision-induced dissociation (CID) shows
potential to satisfy this requirement, as the vibrational activation / dissociation of
protonated N-glycopeptides has been observed to access cleavage of either glycosidic
bonds of the glycan or amide bonds of the peptide in an energy-resolved manner.
Nevertheless, the relative energy requirement for these fragmentation pathways varies
considerably among analytes. This research addresses the influence of proton mobility on
the vibrational energy necessary to achieve either glycan or peptide cleavage in a
collection of protonated N-glycopeptide ions. While greater proton mobility of the
precursor ion was found to correlate with lower energy requirements for precursor ion
depletion and appearance of glycosidic fragments, the vibrational energy deposition
necessary for appearance of peptide backbone fragments showed no relation to the
precursor ion proton mobility. These results are consistent with previous observations
suggesting that peptide fragments arise from an intermediate fragment which is generally
of lower proton mobility than the precursor ion. Such findings have potential to facilitate
the rational selection of CID conditions which are best suited to provide either glycan or
peptide cleavage products in MS/MS based glycoproteomic analysis.
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Introduction
Mass spectrometry (MS) based glycoproteomics is an emerging branch of postgenomic analytical science that lies at the intersection of proteomics and glycomics.1-4
While glycoproteomic experiments are conducted with widely varied scopes and
objectives, they are generally aimed at the identification or characterization of
glycosylated proteins; the compositional or structural determination of protein-linked
oligosaccharides; and the association of individual oligosaccharide compositions or
structures with specific sites of attachment to the protein.5-8 Accordingly, a wide
assortment of MS centered tools are actively applied to glycoproteomics.9-12 In many of
these approaches, tandem mass spectrometry (MS/MS) of glycosylated proteolytic
fragments plays a critical role, often serving as the final analytical readout of the
experiment.13-14
Although MS/MS analysis of glycopeptides is analytically demanding
(polypeptide sequence and oligosaccharide connectivity are simultaneously involved),
these experiments can provide a level of molecular detail not afforded by methods which
release the glycan from the protein prior to analysis.15-16 Nevertheless, complete
elucidation of glycopeptide topology requires MS/MS methods capable of providing
information on both the amino acid sequence and the monosaccharide connectivity.
While this is frequently accomplished by combining multiple, complementary ion
fragmentation methods,13-14 several such methods have been shown capable of probing
both the oligosaccharide and polypeptide moieties of glycopeptides. These include
ultraviolet photodissociation (UVPD),17-18 infrared multiphoton dissociation (IRMPD),1922

and low-energy beam-type collision-induced dissociation (CID).23-26
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By a wide margin, CID is the most widely available ion dissociation method for
MS/MS. While a disadvantage of CID is loss of the glycan prior to the onset of peptide
fragmentation, in most cases this does not hinder the localization of N-glycosylation,
which only occurs within the context of a consensus sequon (multiple instances of which
rarely appear on the same proteolytic fragment). Therefore, extending the applicability of
CID for N-glycopeptide analysis is of significant interest. One barrier towards an
expanded role for CID in glycoproteomics is that the distinct energetic requirements for
accessing glycosidic bond cleavages or peptide backbone cleavages are not well
understood in terms of the physicochemical characteristics of the precursor ions.27-28
The present work is focused on the relationship between precursor ion proton
mobility29-30 and optimum collision energies for accessing glycan versus peptide scission.
Energy-resolved CID studies were conducted on a group of protonated N-glycopeptides
in which different amino acid compositions and charge states were represented. In
general, precursor ion proton mobility correlated negatively with the collision energies
necessary to deplete the precursor ion and provide glycosidic cleavage; however, the
collision energies needed to achieve peptide fragmentation had no noticeable relationship
to the proton mobility of the precursor ion. This is consistent with energy-resolved CID
results that show the peptide fragmentation products arise from an intermediate fragment
of low proton mobility. On the whole, these findings suggest that, with adequate
knowledge of the relevant fragmentation processes, CID could be conducted such that the
monosaccharide connectivity and amino acid sequence of protonated N-glycopeptides are
deliberately accessed.
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Materials and Methods
Reagents and materials. Ammonium bicarbonate, bovine ribonuclease B (BRB),
dithiothreitol, formic acid, imidazole, iodoacetamide, proteomics grade trypsin, and urea
were all procured from Sigma-Aldrich (St. Louis, MO, USA). Acetonitrile (HPLC grade)
and water (HPLC grade) were obtained from Fisher Scientific (Fair Lawn, NJ, USA) and
Burdick & Jackson (Muskegon, MI, USA), respectively. Zwitterionic hydrophilic
interaction liquid chromatography (ZIC-HILIC) micropipette tips for solid phase
extraction (SPE) were acquired from Protea Biosciences (Somerset, NJ, USA).
Glycopeptide preparation. A 50 µL aliquot of 2 µg/µL BRB glycoprotein
solution in 8 M urea and 50 mM NH4HCO3 (pH 7.5) was subjected to disulfide bond
reduction by addition of 10 µL of 450 mM dithiothreitol in 50 mM NH4HCO3 (pH 7.5;
incubated 1 h at 55°C). The sample was next subjected to thiol alkylation by treatment
with 10 µL 500 mM iodoacetamide in 50 mM NH4HCO3 (pH 7.5; incubated 1 h at room
temperature and in the dark). A fresh portion (175 µL) of 50 mM NH4HCO3 (pH 7.5) was
added to the reduced and alkylated glycoprotein sample such that the total urea
concentration was reduced to < 2 M. Proteolysis was then performed through addition of
a 5 µL aliquot of 0.5 µg/µL of trypsin (incubated 18 h at 37°C). The resulting tryptic
digest was reduced to ~ 10 µL in volume via vacuum centrifugation (Speed Vac SC110,
Thermo Savant, Holbrook, NY, USA), then reconstituted in 0.1% HCOOH to a final
volume of ~ 100 µL. Glycopeptides from an aliquot of this solution (4 µL reconstituted
digest diluted to a total volume of 20 µL with CH3CN) were enriched and purified using
ZIC-HILIC SPE. Briefly, the SPE micropipette tip was equilibrated with 80% CH3CN /
0.1% HCOOH, loaded with the sample aliquot described above, washed with 80%
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CH3CN / 0.1% HCOOH, and finally eluted in 20 µL 0.1% HCOOH. In some cases,
purified digests were spiked to contain 10 mM imidazole. This was done in order to
enhance the production of glycopeptide ions with lower charge states for study.
Mass spectrometry and data analysis. The purified glycopeptide digest was
prepared for MS analysis by placing a portion of ZIC-HILIC SPE eluate (~ 5-10 µL) into
a home-pulled glass emitter for nanoelectrospray ionization (nESI). This transfer was
accomplished using a Hamilton 10 µL taper-tipped syringe (Reno, NV, USA). The nESI
emitters were prepared from 1.5 - 1.8 x 100 mm melting point capillary tubes (Corning
Pyrex, Corning, NY, USA) with the aid of a vertical micropipette puller (David Kopf
Instruments, Tujunga, CA, USA). The filled emitter was then fitted to a custom-built
holder which made use of a platinum wire to provide the nESI potential directly to the
analyte solution. This apparatus was then adapted onto the commercial nESI source of a
Waters Synapt G2 HDMS quadrupole time of flight (Q-TOF) hybrid mass spectrometer
(Manchester, UK). Ion source conditions for nESI included an emitter potential of 1.0 1.4 kV, a sampling cone potential of 15 - 35 V, an extraction cone potential of 2 - 4 V,
and a temperature of 80°C. For MS/MS experiments, quadrupole selection of precursor
ions was followed by CID in the “trap” region of the instrument (a stacked ring ion guide
containing argon at a pressure of approximately 5.0 x 10-3 mbar). The DC offset (U)
which determined the kinetic energy of ions entering the collision cell was systematically
adjusted in order to obtain energy-resolved CID spectra.
All instrument control and data acquisition was conducted with the use of
MassLynx 4.1 (Waters). Subsequent data handling and graph generation was performed
using IGOR Pro 6.3 (WaveMetrics, Lake Oswego, OR, USA) and SigmaPlot 10.1
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(Systat, Chicago, IL, USA). For schematic purposes, standard one-letter amino acid
abbreviations were used in diagramming the peptide moiety, while glycan structures were
diagrammed using the conventions suggested by Varki et al.31 The assignment of
fragment ions was performed in accord with the formalisms of Domon and Costello (for
glycan fragments) and Roepstorff and Fohlman (for peptide fragments).32-33 In accord
with these systems of nomenclature, lower case letters were used to indicate peptide
fragments, while upper case letters were used to indicate glycan fragments. If multiple
glycan cleavages (or combinations thereof) could plausibly yield a given product ion
mass, the fragment ion was assigned by indicating the composition of losses from the
precursor ion (e.g., [M - Man2]2+). For simplicity, small neutral losses from precursor or
fragment ions (e.g., NH3, H2O) were not labeled in the spectra. Monosaccharide names
were abbreviated as follows: GlcNAc, N-acetylglucosamine; Man, mannose.

Results and Discussion
Overview. As described above, a set of model glycopeptide analytes was prepared
by trypsinolysis of BRB with the goal of quantitatively characterizing the influence of
proton mobility upon the energy-resolved vibrational activation / dissociation pathways
of selected N-glycopeptides. The presence of several potential tryptic cleavage sites in
close proximity to the single glycosylation site of BRB, coupled with the tendency of
glycosylation to sterically interfere with protease action,34-37 resulted in the production of
glycopeptides with multiple amino acid sequences based on a combination of the fully
tryptic cleavage product and various partially tryptic cleavage products. Specifically, Nglycopeptides with the amino acid sequences NLTK, NLTKDR, SRNLTK, and
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SRNLTKDR were obtained. This provided a group of model glycopeptide analytes which
encompassed some key variations in sequence, particularly with respect to the number
and location of basic sites. Protonated glycopeptide ions based on the above peptide
groups carrying the GlcNAc2Man5 high mannose N-glycan were each studied in two
charge states by energy-resolved CID, as described in detail below.
Precursor ion survival curves. MS/MS data were collected via CID for each of
eight glycopeptide precursor ions: NLTK + GlcNAc2Man5 as the [M+H]+ and [M+2H]2+
ions; NLTKDR + GlcNAc2Man5 as the [M+2H]2+ and [M+3H]3+ ions; SRNLTK +
GlcNAc2Man5 as the [M+2H]2+ and [M+3H]3+ ions; and SRNLTKDR + GlcNAc2Man5
as the [M+2H]2+ and [M+3H]3+ ions. In these experiments, CID was conducted at various
applied U values, which were adjusted in 2.5 – 10.0 V increments, depending on the
analyte. The resulting spectra were used to prepare precursor ion survival curves by
plotting the percent fractional area of the precursor ion peak as a function of the applied
collision energy. As depicted in Figure 3.1, this relatively small set of related
glycopeptide precursor ions (i.e., all bearing the same glycan composition, and all derived
from the same glycosylation site) exhibited a remarkably broad range of energydependent stabilities, with the applied U resulting in < 20% precursor ion survival
ranging from approximately 10.0 V – 60.0 V. This underscores a key challenge in the
interrogation of glycopeptide connectivity by CID; namely, the selection of collision
energies yielding CID spectra which are most informative of the overall topology of a
given glycopeptide precursor ion. This is particularly important given the ability of
vibrational activation / dissociation methods to provide fragments which can be
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Figure 3.1. Precursor ion survival curves for each of the glycopeptide ions studied. The sequences of the
peptide moieties and overall ion charge states are given in the inset. In addition, each glycopeptide
harbored the GlcNAc2Man5 N-glycan. Amino acid residues with basic side chains are shown in bold, while
the glycosylated asparagine residue is underlined. Each data point represents the mean of three replicate
measurements; error bars, where visible, represent the standard deviation.

informative of either the oligosaccharide connectivity or the polypeptide sequence,
depending on the amount of vibrational energy deposited.25-26
While Figure 3.1 is useful in illustrating the highly varied degrees of precursor
ion depletion as a function of U (i.e., the instrumental parameter which is most directly
used to determine the amount of vibrational energy deposited into the precursor ion),
comparisons between the stabilities of the various precursor ions are difficult to
rationalize from visual inspection of these data alone. Indeed, the precursor ion survival
behaviors are dictated by not only the compositions of the analyte ions, but also their
charge states and number of vibrational degrees of freedom.38-39 To allow more
meaningful comparisons among the various analytes studied, the initial kinetic energies
which resulted in 50% depletion of the precursor were calculated and normalized for the
number of vibrational modes available to the analyte. This was carried out by first
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applying a linear fit to the steepest region of each precursor ion survival curve, then
determining value of U which corresponded to 50% fractional intensity of the precursor
ion. These values were in turn used to calculate the corresponding initial kinetic energy,
Ek, (expressed with units of eV) of the precursor ion using Equation 3.1:
Ek = z U

Equation 3.1

Here, z represents the precursor ion charge state expressed as an integer multiple of the
fundamental charge. These values, which account for the charge state of the precursor
ion, were further normalized for the number of vibrational degrees of freedom, fv,
available to the precursor ion. For an analyte composed of n atoms:
fv = 3n - 6

Equation 3.2

The vibrational degrees of freedom normalized initial precursor ion kinetic energy, Ek,n,
was then defined and calculated according to:
Ek ,n =

102 Ek
fv

Equation 3.3

where the factor of 102 was applied to provide more convenient values for comparison
(thus, the values of Ek,n are 102 times the number of electron volts per vibrational mode).
The values of Ek,n corresponding to the 50% survivals of all precursor ions studied are
provided in Table 3.1.
In general, the vibrational energy deposition required to deplete 50% of the initial
precursor ion population was found to negatively correlate with proton mobility, as
estimated based on the relative number of charge-carrying protons (nH) and basic amino
acid residues (nB) present. For each precursor ion studied here, the charge-carrying
proton(s) could be described as “mobile,” “partially mobile,” or “nonmobile.” These
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Table 3.1. Potential differences (ΔU) and degrees of freedom normalized initial precursor ion kinetic
energies (Ek,n) resulting in 50% precursor ion survival of each glycopeptide ion studied. The number of
charge-carrying protons (nH) is indicated relative to the number of basic amino acid residues (nB), and
precursor ion charge sates (z) and vibrational degrees of freedom (fv) are given. Within the glycopeptide
compositions, basic amino acid residues are bolded, and the glycosylated asparagine residue is underlined.
The “cleavage intensity ratio” (CIR) is also provided for each precursor ion according to Kapp et al.40
Larger CIR values indicate lower proton mobility, as estimated based upon the precursor ion charge state
and amino acid composition.
50% Precursor
Ion Survival
Glycopeptide Composition
[NLTK+GlcNAc2Man5+2H]2+
nH>nB

nH<nB

z

fv

ΔU

Ek,n

0.73

2

693

14.5

4.18

3+

0.90

3

804

5.5

2.05

[NLTKDR+GlcNAc2Man5+3H]3+

0.90

3

810

3.9

1.44

2.18

1

690

52.2

7.57

[SRNLTK+GlcNAc2Man5+2H]2+

1.56

2

801

26.2

6.54

2+

1.56

2

807

29.8

7.39

[SRNLTKDR+GlcNAc2Man5+3H]3+

1.52

3

900

14.9

4.97

[SRNLTKDR+GlcNAc2Man5+2H]2+

4.58

2

897

41.0

9.14

[SRNLTK+GlcNAc2Man5+3H]

[NLTK+GlcNAc2Man5+H]
nH=nB

CIR

+

[NLTKDR+GlcNAc2Man5+2H]

categories, suggested by Kapp et al., were based on empirically determined “cleavage
intensity ratios” (CIRs) determined according to the relative proportion of fragmentation
products known to be enhanced in the absence of mobile protons.40 Those authors used
the prevalence of such fragments as an indicator of proton mobility for a large number of
peptides studied by CID. Accordingly, CIR values increase with decreasing proton
mobility. In the present experiments, glycopeptide precursor ions with nH > nB, which
thus contained a readily mobile proton (with CIRs ranging from 0.73 – 0.90), exhibited
50% precursor ion survivals at Ek,n values ranging from 1.44 – 4.18. For glycopeptide
ions with nH = nB, thus rendering the protons partially mobile (with CIRs ranging from
1.52 – 2.18), the Ek,n values corresponding to 50% precursor ion survival were
significantly higher on average, ranging from 4.97 – 7.57. Finally, one analyte in which
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all protons were considered nonmobile (CIR of 4.58) had a 50% precursor ion survival
occurring at an Ek,n value of 9.14. Taken together, these data demonstrate that the order of
charge state corrected and vibrational degrees of freedom normalized initial precursor ion
kinetic energies which brought about 50% precursor ion depletion can be rationalized by
proton mobility; that is, those precursor ions characterized by lower proton mobility
required greater vibrational energy deposition per vibrational mode in order to bring
about unimolecular dissociation processes. Nevertheless, the normalized collision
energies needed to access an analytically useful degree of precursor ion fragmentation
varied substantially within this group of glycopeptides which, in many ways, would be
considered quite similar (all derived from the same glycosylation site, and all bearing the
same glycan).
Energy-resolved CID comparisons at various proton mobilities. In order to
further delineate the role of proton mobility in the vibrational activation / dissociation
behavior of glycopeptides, energy-resolved breakdown curves were plotted for each
precursor ion under study. At each collision energy, the total peak areas were determined
for each of several product ion categories: the precursor ion, [M+nH]n+; the larger Y-type
glycosidic bond cleavage products, ΣYn>1; the peptide chain with one remaining GlcNAc
residue attached, Y1; the bare peptide chain, Y0; cross-ring cleavage of the reducing
terminal GlcNAc residue, 0,2X0; and peptide backbone fragmentation products, Σ(b+y).
The fraction of the total spectral peak area arising from fragment ions in each of these
categories were then plotted against collision energy, expressed as the applied ΔU. In
Figure 3.2, CID breakdown curves are presented for three representative glycopeptide
ions with differing proton mobilities: [NLTKDR + GlcNAc2Man5 + 3H]3+ (nH > nB);
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Figure 3.2. Energy-resolved CID breakdown curves for the [NLTKDR + GlcNAc2Man5 + 3H]3+ (a; nH >
nB), [SRNLTK + GlcNAc2Man5 + 2H]2+ (b; nH = nB), and [SRNLTKDR + GlcNAc2Man5 +2H]2+ (c; nH <
nB) glycopeptide ions. Additional explanation is provided in the caption to Figure 3.1.
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[SRNLTK + GlcNAc2Man5 + H]2+ (nH = nB); and [SRNLTKDR + GlcNAc2Man5 + 2H]2+
(nH < nB). The energy-resolved CID breakdown curves for the remaining glycopeptide
ions under study are provided below (Figures 3.3-3.7). As we have previously noted of
other glycopeptide ions,25-26 the energy-resolved CID behaviors of these precursors were
found to be qualitatively similar despite significant differences in proton mobility. In
each case, the precursor ions first dissociated to give rise to Yn>1 glycan fragments. With
further increases in vibrational energy deposition, the Yn>1 dissociation products
gradually gave way to an abundance of Y1 ions. Finally, at sufficiently high collision
energies, a decline in the intensity of Y1 ions was accompanied by the production of 0,2X0,
Y0, and peptide b and y ions. Indeed, for all of the glycopeptide ions studied here,
fragment ions of these various types appeared in the same qualitative order with
increasing collision energy. Nevertheless, there are substantial quantitative differences in
the energy-resolved CID behaviors of the glycopeptide ions. That is, the specific range of

Figure 3.3. Energy-resolved CID breakdown curve for the [NLTK + GlcNAc2Man5 + 2H]2+ glycopeptide
ion. Amino acid residues with basic side chains are shown in bold, while the glycosylated asparagine
residue is underlined. Each data point represents the mean of three replicate measurements; error bars,
where visible, represent the standard deviation.
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ΔU values which yield a given type of fragment ion is widely varied among precursor
ions of different proton mobilities.

Figure 3.4. Energy-resolved CID breakdown curve for the [SRNLTK + GlcNAc2Man5 + 3H]3+
glycopeptide ion. Amino acid residues with basic side chains are shown in bold, while the glycosylated
asparagine residue is underlined. Each data point represents the mean of three replicate measurements;
error bars, where visible, represent the standard deviation.

Figure 3.5. Energy-resolved CID breakdown curve for the [NLTK + GlcNAc2Man5 + H]+ glycopeptide
ion. Amino acid residues with basic side chains are shown in bold, while the glycosylated asparagine
residue is underlined. Each data point represents the mean of three replicate measurements; error bars,
where visible, represent the standard deviation.
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Figure 3.6. Energy-resolved CID breakdown curve for the [NLTKDR + GlcNAc2Man5 + 2H]2+
glycopeptide ion. Amino acid residues with basic side chains are shown in bold, while the glycosylated
asparagine residue is underlined. Each data point represents the mean of three replicate measurements;
error bars, where visible, represent the standard deviation.

Figure 3.7. Energy-resolved CID breakdown curve for the [SRNLTKDR + GlcNAc2Man5 + 3H]3+
glycopeptide ion. Amino acid residues with basic side chains are shown in bold, while the glycosylated
asparagine residue is underlined. Each data point represents the mean of three replicate measurements;
error bars, where visible, represent the standard deviation.

To provide a means for quantitative comparison of the vibrational energy required
to access glycosidic and peptide backbone cleavages, additional Ek,n values were
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calculated for the corresponding regions of the energy-resolved CID breakdown curves.
First, Ek,n values which brought about the maximum total intensity of Yn>1 glycosidic
fragments were determined by fitting the most abundant three to four points of the ΣYn>1
curve with a quadratic function (i.e., downward opening parabola), and calculating the
inflection point of this function. This was taken to represent the approximate value of ∆U
which provided maximum glycosidic fragmentation. Similarly, the ∆U value at which the
Σ(b+y) peptide fragments first constituted 20% of the total integrated peak area was
obtained from a linear fit of the Σ(b+y) line in the energy-resolved CID breakdown plot.
The 20% intensity was chosen because, while most of the glycopeptides eventually
yielded peptide b and y ions to comprise approximately 40% or more of the integrated
peak area (e.g., Figure 3.2b-c), in two cases only about 20% of the peak area could be
attributed to peptide backbone cleavage products (e.g., Figure 3.2a). Thus, the 20%
peptide fragment appearance value was used to enable reasonable comparisons among
the different precursor ions. In the cases of both maximum ΣYn>1 intensity and 20%
Σ(b+y) intensity, the ∆U values of interest were used to calculate the corresponding Ek,n
values (cf. Equations 1-3). For each glycopeptide ion under study, these Ek,n values are
summarized in Table 3.2.
Similar to the results for precursor ion survival (cf. Table 3.1), the Ek,n values
which yielded maximum ΣYn>1 intensity were seen to correlate with the CIR values
assigned to each peptide moiety. That is, the Ek,n values correlate inversely with proton
mobility, as expected. For precursor ions with a readily mobile proton (nH > nB), Ek,n
values ranged from 4.74 – 5.56; for precursor ions with a partially mobile proton (nH =
nB), Ek,n values ranged from 7.67 – 8.65; and for the precursor ion with no mobile protons
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Table 3.2. Potential differences (ΔU) and degrees of freedom normalized initial precursor ion kinetic
energies (Ek,n) resulting in the maximum proportion of glycosidic bond cleavage products (∑Yn>1), and
those necessary for peptide backbone cleavage products (∑b,y) to constitute 20% of the integrated peak
area for each glycopeptide ion. Additional explanation is provided in the caption to Table 3.1.

Max ∑Yn>1
Intensity

nH>nB

20% ∑(b,y)
Intensity

Glycopeptide Composition

CIR

z

fv

ΔU

Ek,n

ΔU

Ek,n

[NLTK+GlcNAc2Man5+2H]2+

0.73

2

693

17.0

4.91

42.9

12.38

[SRNLTK+GlcNAc2Man5+3H]3+

0.90

3

804

14.9

5.56

35.3

13.17

[NLTKDR+GlcNAc2Man5+3H]3+

0.90

3

810

12.8

4.74

35.2

13.04

[NLTK+GlcNAc2Man5+H]+

2.18

1

690

58.8

8.52

75.2

10.90

[SRNLTK+GlcNAc2Man5+2H]2+

1.56

2

801

31.3

7.82

49.9

12.46

[NLTKDR+GlcNAc2Man5+2H]2+

1.56

2

807

34.9

8.65

56.2

13.93

[SRNLTKDR+GlcNAc2Man5+3H]3+

1.52

3

900

23.0

7.67

34.5

11.50

[SRNLTKDR+GlcNAc2Man5+2H]2+

4.58

2

897

46.2

10.30

52.4

11.68

nH=nB

nH<nB

(nH < nB), Ek,n value was 10.30. This underscores the influence of proton mobility upon
the vibrational energy necessary to achieve the highest proportion of glycosidic scission
products. Contrastingly, the Ek,n values that produced peptide b and y ions with an
aggregate of 20% total spectral peak intensity fell in a relatively narrow range. All of
these Ek,n values ranged from 10.90 – 13.93, with no clear relation to the proton mobility
of the precursor ion. While initially unexpected, this can be rationalized by noting that, as
illustrated by the energy-resolved CID breakdown curves (Figure 3.2), the Y0, b, and y
ions appear to be tertiary products of sequential fragmentation, arising largely from
further fragmentation of the Y1 ion. This suggests that the vibrational energy required to
achieve peptide amide bond scission is not a function of the precursor ion proton
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mobility, but dictated by the proton mobility of the Y1 fragment. As these Y1 fragments
typically had lower charge states than the precursor ion (as will be shown and further
discussed below), their proton mobilities were thus lower than those of the corresponding
precursor ions. As a consequence, the vibrational degrees of freedom normalized initial
precursor ion kinetic energies that bring about polypeptide b and y ions are quite similar
among precursor ions – even those with very dissimilar precursor ion survival energies
and glycosidic fragment appearance energies – because in each case the peptide sequence
ions originate from an intermediate fragment with no mobile protons. These general
observations could eventually be of considerable practical usefulness for the deliberate
production of amino acid sequence information for unknown glycopeptides by CID.
CID spectrum comparisons at various proton mobilities. With knowledge of
how the precursor ion characteristics of protonated glycopeptides influence their energyresolved CID behaviors, collision energies could be selected such that information on
either the oligosaccharide connectivity or the polypeptide sequence was intentionally
accessed. Figure 3.8 provides the CID spectra of the same representative glycopeptide
ions for which energy-resolved CID breakdown curves were shown in Figure 3.2. In
these spectra, collision energies chosen to approximate the Ek,n values corresponding to
maximum ΣYn>1 intensity (cf. Table 3.2). In each case, the CID spectra exhibited
extensive series of Y-type fragment ions yielding the complete connectivity of the
oligosaccharide group, down to at least the Y1 (and in one case, Y0) ion. In addition to the
Y-type dissociation products, a prominent cross-ring cleavage product (0,2X0) was noted in
the CID spectrum of the [SRNLTKDR + GlcNAc2Man5 + 2H]2+ ion (Figure 3.8c). While
informative as to the general topology and composition of the glycan, none of these
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Figure 3.8. CID spectra for the [NLTKDR + GlcNAc2Man5 + 3H]3+ (a; nH > nB), [SRNLTK +
GlcNAc2Man5 + 2H]2+ (b; nH = nB), and [SRNLTKDR + GlcNAc2Man5 +2H]2+ (c; nH < nB). The applied
precursor acceleration potentials (ΔU) are indicated, and were chosen to bring about the maximum
proportion of glycosidic bond cleavage products (cf. Table 3.2). Cleavage maps summarizing the
fragmentation of each glycopeptide are provided to the right of each spectrum.

spectra were found to yield any detectable peptide backbone fragmentation. The same
glycopeptide ions were then interrogated at collision energies consistent with Ek,n values
known to bring about ≥ 20% Σ(b+y) intensity (cf. Table 3.2); the resulting dissociation
spectra are provided in Figure 3.9. Under these conditions, each precursor ion could be
fragmented to yield significant information on the amino acid connectivity, with the
peptide sequence coverages for the [NLTKDR + GlcNAc2Man5 + 3H]3+, [SRNLTK +
GlcNAc2Man5 + 2H]2+, and [SRNLTKDR + GlcNAc2Man5 + 2H]2+ glycopeptide ions
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Figure 3.9. CID spectra for the [NLTKDR + GlcNAc2Man5 + 3H]3+ (a; nH > nB), [SRNLTK +
GlcNAc2Man5 + 2H]2+ (b; nH = nB), and [SRNLTKDR + GlcNAc2Man5 +2H]2+ (c; nH < nB). The applied
precursor acceleration potentials (ΔU) are indicated, and were chosen to achieve peptide backbone cleavage
such that these products constituted approximately 20% of the integrated peak area (cf. Table 2). Cleavage
maps summarizing the fragmentation of each glycopeptide are provided to the right of each spectrum.

reaching 100.0%, 80.0%, and 71.5%, respectively. In addition to peptide sequence ions,
Y2, Y1, Y0, and 0,2X0 cleavages were apparent in the spectra. Strikingly, all of the observed
peptide sequence ions were singly charged, regardless of the charge state or proton
mobility of the initial precursor ions. Moreover, at these collision energies the charge
states of all of the Y1 ions were such that these fragments lacked a mobile proton (singly
charged in the case of the [NLTKDR + GlcNAc] and [SRNLTK + GlcNAc] Y1
fragments; doubly charged in the case of the [SRNLTKDR + GlcNAc] Y1 fragment). The
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tendency of protonated glycopeptide ions is evidently to either lose charge (likely due to
production of carbohydrate oxonium ions41-42) to render a Y1 fragment with lower proton
mobility than the precursor, or to retain charge in cases where the initial precursor ion
had no mobile protons. In all of the cases examined here, this causes the intermediate Y1
fragment (which eventually gives rise to peptide b and y ions) to harbor only nonmobile
protons. Thus, protonated glycopeptide ions can behave quite similarly with respect to the
vibrational mode normalized collision energies which bring about peptide backbone
fragments, even when they greatly differ in the energetics of precursor ion survival and
glycan fragment appearance.

Conclusions
This report elaborates on the relation of precursor ion proton mobility to the
relative energy requirements for glycan and peptide cleavage in vibrational activation /
dissociation of representative N-glycopeptides. Both the 50% precursor ion survival
energies and the energies which resulted in optimum production of glycan fragments
varied widely among the precursor ions under study, and generally increased with
decreasing proton mobility. Conversely, the energies at which peptide backbone
fragments were readily accessed exhibited little or no correlation with the proton mobility
of the precursor ion. This apparent disconnect is explained by the observation that peptide
backbone fragments are products of sequential dissociation, and arise largely from the
intermediate Y1 fragment. For all of the cases studied here, the Y1 fragments were
produced in charge states that afforded only nonmobile protons, regardless of the charge
state or proton mobility of the precursor ion. An important consequence of this finding is
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that the degrees of freedom normalized vibrational energy deposition required to render
peptide sequence ions was surprisingly similar among the glycopeptide ions studied, even
when their other energy-resolved CID characteristics were quite disparate. While further
study is needed in order to determine whether these trends are broadly representative of
much larger populations of protonated N-glycopeptides, the current results are
encouraging in that they suggest the potential that glycan cleavage and peptide cleavage
can be deliberately accessed for putative unknowns based on characteristics such as
charge state and molecular weight. This, in turn, intimates the possibility of an expanded
role for CID in glycoproteomic analysis.
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Appendix A
Brief Summary of This Work
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The work presented in this thesis emphasizes that the application of energyresolved collision-induced dissociation can yield significant coverage of both the
monosaccharide connectivity and the amino acid sequence of protonated N-linked
glycopeptide ions. As a general principle, increasing collision energies lead to multiple,
consecutive generations of product ions that appear in a particular order: Yn>1 glycan
cleavages (primary fragment ions), Y1 glycan cleavage (secondary fragment ions), and b,
y peptide cleavages (tertiary fragment ions). This qualitative behavior applies to all
protonated N-glycopeptides studied here, regardless of charge state, glycan type, or
peptide composition. However, the quantitative relationships between collision energies
and fragment ion types did vary considerably among different analyte ions. These
quantitative differences were explained in part by precursor ion proton mobility. Proton
mobility of the precursor ion was found to correlate negatively with the collision energies
required to deplete the precursor ion, and to produce primary fragmentation products
(Yn>1 glycan fragments). By contrast, the production of peptide b and y ions was found to
have no relation to precursor ion proton mobility. This is consistent with the observation
that the peptide b and y cleavages are tertiary fragment ions, arising from the secondary
Y1 fragment ions. The apparent disconnect between the precursor ion proton mobility and
the collision energies needed to produce peptide fragmentation is also in accord with the
observation that Y1 fragment ions generally have lower proton mobilities than their
respective precursor ions (largely due to loss of charge to carbohydrate oxonium ions).
Overall, these results suggest the possibility that precursor ion characteristics, including
proton mobility, can be predictive of the collision energies needed to intentionally access
glycan or peptide cleavage products.

